Larvol Delta - BioPath-Holdings-Announces-First-Patient-Dosed-in-Amended-Stage-2-of-the-Phase-2-Clinical-Trial-Evaluating-Prexigebersen-in-Acute-Myeloid-Leukemia

Venclexta (venetoclax) - Roche, AbbVie

prexigebersen (BP1001) - Bio-Path

decitabine - Generic mfg.

https://www.globenewswire.com/news-release/2020/08/13/2077779/0/en/Bio-Path-Holdings-Announces-First-Patient-Dosed-in-Amended-Stage-2-of-the-Phase-2-Clinical-Trial-Evaluating-Prexigebersen-in-Acute-Myeloid-Leukemia.html

Aug 13, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next